213 related articles for article (PubMed ID: 7531216)
1. Human immunodeficiency virus type 2 (HIV-2) env gene analysis: prediction of glycoprotein epitopes important for heterotypic neutralization and evidence for three genotype clusters within the HIV-2a subtype.
Breuer J; Douglas NW; Goldman N; Daniels RS
J Gen Virol; 1995 Feb; 76 ( Pt 2)():333-45. PubMed ID: 7531216
[TBL] [Abstract][Full Text] [Related]
2. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
3. Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france.
Damond F; Apetrei C; Robertson DL; Souquière S; Leprêtre A; Matheron S; Plantier JC; Brun-Vézinet F; Simon F
Virology; 2001 Feb; 280(1):19-30. PubMed ID: 11162815
[TBL] [Abstract][Full Text] [Related]
4. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
5. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
6. Molecular analyses of HIV-1 group O and HIV-2 variants from Africa.
Hunt JC; Brennan CA; Golden AM; Yamaguchi J; Lund JK; Vallari AS; Hickman RK; Zekeng L; Gürtler LG; Hampl H; Kaptué L; Devare SG
Leukemia; 1997 Apr; 11 Suppl 3():138-41. PubMed ID: 9209322
[TBL] [Abstract][Full Text] [Related]
7. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
[TBL] [Abstract][Full Text] [Related]
8. Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2.
Björling E; Chiodi F; Utter G; Norrby E
J Immunol; 1994 Feb; 152(4):1952-9. PubMed ID: 8120399
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes.
Chang SY; Vithayasai V; Vithayasai P; Essex M; Lee TH
J Infect Dis; 2000 Aug; 182(2):442-50. PubMed ID: 10915074
[TBL] [Abstract][Full Text] [Related]
10. Antigenic variation of SIV: mutations in V4 alter the neutralization profile.
Kinsey NE; Anderson MG; Unangst TJ; Joag SV; Narayan O; Zink MC; Clements JE
Virology; 1996 Jul; 221(1):14-21. PubMed ID: 8661410
[TBL] [Abstract][Full Text] [Related]
11. A model for alignment of Env V1 and V2 hypervariable domains from human and simian immunodeficiency viruses.
Lamers SL; Sleasman JW; Goodenow MM
AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1169-78. PubMed ID: 8844021
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from guinea-bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa.
Andersson S; Norrgren H; Dias F; Biberfeld G; Albert J
Virology; 1999 Sep; 262(2):312-20. PubMed ID: 10502510
[TBL] [Abstract][Full Text] [Related]
13. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
Neurath AR; Strick N; Lee ES
J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
[TBL] [Abstract][Full Text] [Related]
14. Population sequence analysis of a simian immunodeficiency virus (32H reisolate of SIVmac251): a virus stock used for international vaccine studies.
Almond N; Jenkins A; Slade A; Heath A; Cranage M; Kitchin P
AIDS Res Hum Retroviruses; 1992 Jan; 8(1):77-88. PubMed ID: 1736942
[TBL] [Abstract][Full Text] [Related]
15. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41.
Jiang SB; Lin K; Neurath AR
J Exp Med; 1991 Dec; 174(6):1557-63. PubMed ID: 1836013
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates.
Beirnaert E; Nyambi P; Willems B; Heyndrickx L; Colebunders R; Janssens W; van der Groen G
J Med Virol; 2000 Sep; 62(1):14-24. PubMed ID: 10935983
[TBL] [Abstract][Full Text] [Related]
18. Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type I show increased sensitivity to neutralization by human sera.
McKeating JA; Zhang YJ; Arnold C; Frederiksson R; Fenyö EM; Balfe P
Virology; 1996 Jun; 220(2):450-60. PubMed ID: 8661395
[TBL] [Abstract][Full Text] [Related]
19. The neutralization relationship of HIV type 1, HIV type 2, and SIVcpz is reflected in the genetic diversity that distinguishes them.
Nyambi PN; Willems B; Janssens W; Fransen K; Nkengasong J; Peeters M; Vereecken K; Heyndrickx L; Piot P; van der Groen G
AIDS Res Hum Retroviruses; 1997 Jan; 13(1):7-17. PubMed ID: 8989422
[TBL] [Abstract][Full Text] [Related]
20. Neutralising epitopes of simian immunodeficiency virus envelope glycoprotein.
Kent KA
J Med Primatol; 1995 May; 24(3):145-9. PubMed ID: 8751054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
